Difficulty: Medium
Average Score: 89%
Practice
Five patient subtypes have hypertension. Which of the following patients would best respond to a calcium channel blocker?
Correct answer
A
Rationale
In choosing the correct answer, which is option A, a 60-year-old black man, for a patient subtype who would best respond to a calcium channel blocker for hypertension, we need to consider factors like race and age.
Calcium channel blockers are known to be more effective in black patients compared to other antihypertensive medications due to genetic variations that affect the renin-angiotensin-aldosterone system. Black individuals tend to have higher renin levels, making them more responsive to calcium channel blockers.
Option B, a 45-year-old white man, is less likely to benefit from a calcium channel blocker as younger individuals generally respond better to other classes of antihypertensive drugs.
Option C, a 50-year-old white man, falls within an age group where calcium channel blockers may not be the first-line treatment choice, especially in white individuals.
Option D, a 55-year-old white woman, is less likely to be the best candidate for a calcium channel blocker based on gender and age considerations.
Educationally, understanding the nuances of drug responsiveness based on patient characteristics like race and age is crucial in personalized medicine and optimizing treatment outcomes. Tailoring medication choices to individual patient profiles can lead to more effective and targeted therapeutic interventions.
Calcium channel blockers are known to be more effective in black patients compared to other antihypertensive medications due to genetic variations that affect the renin-angiotensin-aldosterone system. Black individuals tend to have higher renin levels, making them more responsive to calcium channel blockers.
Option B, a 45-year-old white man, is less likely to benefit from a calcium channel blocker as younger individuals generally respond better to other classes of antihypertensive drugs.
Option C, a 50-year-old white man, falls within an age group where calcium channel blockers may not be the first-line treatment choice, especially in white individuals.
Option D, a 55-year-old white woman, is less likely to be the best candidate for a calcium channel blocker based on gender and age considerations.
Educationally, understanding the nuances of drug responsiveness based on patient characteristics like race and age is crucial in personalized medicine and optimizing treatment outcomes. Tailoring medication choices to individual patient profiles can lead to more effective and targeted therapeutic interventions.